Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Détails bibliographiques
Auteurs principaux:	Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Format:	Journal article
Publié:	2009

Documents similaires